Recursion pharmaceuticalsGuide & Pricing
Core Identity Overview
Recursion Pharmaceuticals operates the Recursion OS, an AI-driven platform that leverages massive biological datasets (spanning over 50 petabytes) and automated wet lab experiments to map disease biology at the cellular level for drug discovery and development.
🎁 Free Tier Detailed Specs
Data Access
Access to proprietary data and AI models is available through strategic partnerships.
Recommended For These Audiences
- ✔Biotech Scientists and Researchers: Scientists who need to map complex biological pathways and discover novel drug targets using integrated AI and large-scale omics data.
- ✔Pharmaceutical Developers: Teams focused on accelerating the discovery, preclinical testing, and development of new therapies for challenging conditions like oncology and rare diseases.
Frequently Asked Questions (FAQ)
Q. What is the core function of the Recursion OS?
The Recursion OS is an AI-driven platform that integrates massive biological datasets, machine learning models, and automated wet lab results to map disease biology and accelerate the drug discovery pipeline.
Q. How does Recursion speed up drug discovery?
By using AI to analyze vast biological data and automate cell experiments, the platform rapidly identifies novel targets and designs optimized molecules, significantly reducing the time from target identification to IND-enabling studies.
Q. What kind of data does Recursion utilize?
The platform utilizes proprietary biological and chemical datasets spanning phenomics, transcriptomics, proteomics, ADME, and de-identified patient data, totaling over 50 petabytes.